CD33 and hepatocellular carcinoma: Our study corroborates previous findings that the frequency of CD11b+/CD33+/CD14+/HLA‐DRlow/− mMDSCs is significantly elevated in HCC patients compared to cirrhotic patients and HC.6, 18, 19